Xiangyu Medical Co.,Ltd

SHSE:688626 Stock Report

Market Cap: CN¥5.3b

Xiangyu MedicalLtd Future Growth

Future criteria checks 5/6

Xiangyu MedicalLtd is forecast to grow earnings and revenue by 36.6% and 25.4% per annum respectively. EPS is expected to grow by 36.9% per annum. Return on equity is forecast to be 13.6% in 3 years.

Key information

36.6%

Earnings growth rate

36.9%

EPS growth rate

Medical Equipment earnings growth26.1%
Revenue growth rate25.4%
Future return on equity13.6%
Analyst coverage

Low

Last updated11 Nov 2024

Recent future growth updates

CN¥50.78: That's What Analysts Think Xiangyu Medical Co.,Ltd (SHSE:688626) Is Worth After Its Latest Results

Apr 21
CN¥50.78: That's What Analysts Think Xiangyu Medical Co.,Ltd (SHSE:688626) Is Worth After Its Latest Results

Recent updates

Xiangyu MedicalLtd (SHSE:688626) Has A Somewhat Strained Balance Sheet

Dec 11
Xiangyu MedicalLtd (SHSE:688626) Has A Somewhat Strained Balance Sheet

Why Xiangyu MedicalLtd's (SHSE:688626) Soft Earnings Are Just The Beginning Of Its Problems

Nov 06
Why Xiangyu MedicalLtd's (SHSE:688626) Soft Earnings Are Just The Beginning Of Its Problems

Further Upside For Xiangyu Medical Co.,Ltd (SHSE:688626) Shares Could Introduce Price Risks After 41% Bounce

Oct 09
Further Upside For Xiangyu Medical Co.,Ltd (SHSE:688626) Shares Could Introduce Price Risks After 41% Bounce

Xiangyu Medical Co.,Ltd (SHSE:688626) Looks Inexpensive But Perhaps Not Attractive Enough

Aug 24
Xiangyu Medical Co.,Ltd (SHSE:688626) Looks Inexpensive But Perhaps Not Attractive Enough

Xiangyu MedicalLtd (SHSE:688626) Seems To Use Debt Quite Sensibly

Jul 04
Xiangyu MedicalLtd (SHSE:688626) Seems To Use Debt Quite Sensibly

Xiangyu MedicalLtd's (SHSE:688626) Performance Raises Some Questions

Apr 24
Xiangyu MedicalLtd's (SHSE:688626) Performance Raises Some Questions

CN¥50.78: That's What Analysts Think Xiangyu Medical Co.,Ltd (SHSE:688626) Is Worth After Its Latest Results

Apr 21
CN¥50.78: That's What Analysts Think Xiangyu Medical Co.,Ltd (SHSE:688626) Is Worth After Its Latest Results

Capital Allocation Trends At Xiangyu MedicalLtd (SHSE:688626) Aren't Ideal

Apr 18
Capital Allocation Trends At Xiangyu MedicalLtd (SHSE:688626) Aren't Ideal

Pinning Down Xiangyu Medical Co.,Ltd's (SHSE:688626) P/E Is Difficult Right Now

Mar 26
Pinning Down Xiangyu Medical Co.,Ltd's (SHSE:688626) P/E Is Difficult Right Now

Earnings and Revenue Growth Forecasts

SHSE:688626 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,323369N/A3832
12/31/20251,089302N/A3312
12/31/2024882241N/A2542
9/30/2024710121-295152N/A
6/30/2024748176-335160N/A
3/31/2024771228-302209N/A
12/31/2023745227-251228N/A
9/30/2023674212-201267N/A
6/30/2023602193-89269N/A
3/31/2023547154-19247N/A
12/31/2022489125-16187N/A
9/30/2022529163-23184N/A
6/30/2022528156-42148N/A
3/31/2022508177-21137N/A
12/31/202152320232166N/A
9/30/202153321234199N/A
6/30/202152620546189N/A
3/31/2021531210107246N/A
12/31/202049619677216N/A
12/31/2019427129135156N/A
12/31/2018359806774N/A
12/31/201728964N/A59N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688626's forecast earnings growth (36.6% per year) is above the savings rate (2.8%).

Earnings vs Market: 688626's earnings (36.6% per year) are forecast to grow faster than the CN market (25.7% per year).

High Growth Earnings: 688626's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688626's revenue (25.4% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 688626's revenue (25.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688626's Return on Equity is forecast to be low in 3 years time (13.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 03:16
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xiangyu Medical Co.,Ltd is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Shuo SongCitic Securities Co., Ltd.
Xiao Wei LinEverbright Securities Co. Ltd.